Alkem Labs is a stock to consider. It has recently broken out and is trading at all-time highs. Given the sustained buying interest and long build-up in the derivative data, Alkem Labs may continue to rise. The target is around 6,000 to 6,050, with a stop loss at 5,720.
Kaynes shares plunge 43% from October peak. Is a tactical rebound on the cards or more pain ahead?
Kaynes has plunged 43.5% from its October peak, with Friday’s 12.5% drop marking the steepest single-day decline. Momentum indicators remain bearish, signaling a risk of